Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001493152-25-011175

Options or other derivatives

  • CEO, President acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mack Gene · CEO, President

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-20 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +200,000 200,000 D
Loading xslF345X05/ownership.xml…